State Policies and Buprenorphine Prescribing by Nurse Practitioners and Physician Assistants.
State Policies and Buprenorphine Prescribing by Nurse Practitioners and Physician Assistants.
复制标题
护士从业者和医师助理的国家政策和丁丙诺啡处方。
DOI:
10.1177/10775587221086489
复制
发表时间:
2022-12
期刊:
影响因子:
--
通讯作者:
Stein BD
中科院分区:
文献类型:
--
作者:
Harrison JM;Kerber R;Andraka-Christou B;Sorbero M;Stein BD
Nurse practitioner (NP) and physician assistant (PA) prescribing can increase access to buprenorphine treatment for opioid use disorder. In this cross-sectional study, we used deidentified claims from approximately 90% of U.S. retail pharmacies (2017–2018) to examine the association of state policies with the odds of receiving buprenorphine treatment from an NP/PA versus a physician, overall and stratified by urban/rural status. From 2017 to 2018, the percentage of buprenorphine treatment episodes prescribed by NPs/PAs varied widely across states, from 0.4% in Alabama to 57.2% in Montana. Policies associated with greater odds of buprenorphine treatment from an NP/PA included full scope of practice (SOP) for NPs, full SOP for PAs, Medicaid pay parity for NPs (reimbursement at 100% of the fee-for-service physician rate), and Medicaid expansion. Although most findings with respect to policies were similar in urban and rural settings, the association of Medicaid expansion with NP/PA buprenorphine treatment was driven by rural counties.
登录
查看更多内容
影响因子:
2.5
作者:
Germack, Hayley D.;Harrison, Jordan;Martsolf, Grant R.
通讯作者:
Martsolf, Grant R.
影响因子:
3.8
作者:
Abraham, Amanda J.;Lawler, Emily C.;Bradford, W. David
通讯作者:
Bradford, W. David
DOI:
10.1377/hlthaff.2017.1158
发表时间:
2018-06
期刊:
Health affairs (Project Hope)
影响因子:
--
作者:
Barnes H;Richards MR;McHugh MD;Martsolf G
通讯作者:
Martsolf G
影响因子:
4.9
作者:
Andrilla, C. Holly A.;Patterson, Davis G.
通讯作者:
Patterson, Davis G.
DOI:
10.1097/01.jaa.0000475463.23218.c9
发表时间:
2016-01-01
影响因子:
1.1
作者:
Cawley, James F.;Lane, Steven;Bush, Elizabeth
通讯作者:
Bush, Elizabeth